2023 News

NCI Webinar Series: Novel Chemical Approaches for Targeting Fusion Oncoproteins; August 19 - October 21, 2022

Posted March 27, 2023
Source: DCTD Meetings

Preventing Resistance to Cancer Targeted Therapies

Posted March 17, 2023
Source: NCI Cancer Currents Blog

Tucatinib Approved for HER2-Positive Colorectal Cancer

Posted February 10, 2023
Source: NCI Cancer Currents Blog

Blinatumomab Extends Life for People with ALL in Remission

Posted January 25, 2023
Source: NCI Cancer Currents Blog

Kisqali Plus Hormone Therapy for Metastatic Breast Cancer

Posted January 11, 2023
Source: NCI Cancer Currents Blog